Livogiva sol inj 20 mcg/80mcl, , Livogiva sol inj 20 mcg/80mcl stylo pré 1 pce
7680678260017
CH-67826
H05AA02
1 / 3
google
Details
- Product number
- -
- CPT
- -
- Packaging group
- -
- Unit
- -
Articles (1)
Livogiva 20 mcg/80 mcl, Injektionslösung im Fertigpen
Injektionslösung im Fertigpen
1
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
teriparatidum ADNr
|
250.0 UG | Substance | Wirkstoff (Principe actif) |
|
acidum aceticum glaciale
|
- | Substance | HNIDK |
|
natrii acetas trihydricus
|
- | Substance | HNIDK |
|
mannitolum
|
- | Substance | HNIDK |
|
metacresolum
|
- | Substance | Konservierungsstoff (Conservateur) |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
teriparatidum ADNr
|
20.0 UG | Substance | WIZUS |
|
natrium
|
1.4 UG | Substance | HBESI |
Reimbursement information
Public price
CHF 278.40
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/11/2021
Authorization holder
Future Health Pharma GmbH
8620 Wetzikon ZH
Authorization information
- Swissmedic authorization number
- 67826
- Drug name
- Livogiva, Injektionslösung im Fertigpen
- Galenic form
- INLFP
- ATC Code
- H05AA02
- Authorization status
- Revoked/Withdrawn
- Dispensation category
- B
- First authorization
- 17/02/2021
- Authorization expiration date
- 15/07/2025
- IT number
- 07.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- LIVOGIVA sol inj 20 mcg/80mcl stylo pré 2.7 ml
- Description (DE)
- LIVOGIVA Inj Lös 20 mcg/80mcl Fertpen 2.7 ml
- Market launch
- 17/02/2021
- Market withdrawal
- 16/07/2025
- Narcotic (BTM)
- No